You are here

P&T News

February 20

Nearly 68% of patients treated with AR101 could tolerate peanut protein
Tablets are also indicated to treat drug-induced extrapyramidal reactions
But lawmakers are far from united on the issue
New CEO believes “breakthrough innovations” are key to future growth
Law journal article considers the strategy’s legal and ethical implications

February 19

First treatment for patients with inoperable tumors after chemoradiation
Benefits reported in treating plaque psoriasis, oral ulcers, and genital psoriasis
Award was largest ever in a U.S. patent case

February 16

So far, 20,000 people have been hospitalized
In interim assessment of vaccine effectiveness, young children do better

February 15

FDA permits marketing of Viz.AI Contact to speed treatment
Did other treatments confound the results?
Novel clinical trial endpoint, metastasis-free survival, was used in evaluation
Quick testing option may help reduce CT scans, radiation exposure
U.S. health care spending to climb 5.3% in 2018, agency predicts

February 13

Senator’s investigation found a “lack of transparency” surrounding the donations
Manufacturing problems caused million-dollar delay
$100 billion “investment” in basic science accounted for 20% of NIH spending in 2010–2016
White House report proposes several ways to lower drug prices

Pages